KD101 (@KushDaddyOG101) header
KD101 (@KushDaddyOG101) profile picture
Joined May 2009
Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)Photo by KD101 (@KushDaddyOG101)
Cannabis is an easy win for an administration in need of a win badly Timing has never been better Dems take it if it drags into January $MSOS $TRLV $GTBIF $CURLF $VREOF $VRNO $CRLBF $GLAS
6
2
32
1,655
Medical marijuana is now being delivered via the U.S. Postal Service in Georgia, making it the first state to approve medical cannabis shipments to registered patients through postal and other authorized carriers. Launched on November 17 by Botanical Sciences and Edibles. com, the program uses USPS certified mail to fulfill orders. While the service is initially rolling out to a limited group of patients, there are plans to expand availability statewide. To place an order, buyers must verify their patient registration, identity, and delivery details, and all shipments are strictly restricted to eligible patients residing within Georgia. Unlike home-delivery models operated directly by licensed dispensaries in other states, Georgia's approach relies on established commercial shipping carriers. For patients who live hours away from a dispensary, cannot drive, or face mobility limitations, mail delivery could remove a major barrier to obtaining their medication. Even so, state authorization has not resolved lingering federal questions. A USPS spokesperson stated that medical marijuana remains nonmailable while postal authorities evaluate the implications of its federal reclassification, whereas Georgia regulators and the participating companies maintain that the initiative is lawful. As a result, this rollout does not signify nationwide permission to mail cannabis or confirmed federal postal endorsement. The new delivery option arrives amid rapid growth in Georgia's medical cannabis program, which climbed from roughly 34,500 registered patients in March to nearly 65,000 by early November. Regulatory updates that took effect in July also broadened patient eligibility and expanded available products, allowing cannabis flower for vaporization while keeping smoking prohibited.
13
58
10
281
28,324
Entire US Cannabis sector = $9.5B EV 1x 2027 Revenue 4.5x EBITDA On the brink of federal reform ending 100yr prohibition $MSOS $TRLV $CURLF $GTBIF $VREOF $VRNO $CRLBF
2
7
45
1,959
Friendly reminder $GTBIF now trading at 3.7x 2027 EBITDA $MSOS $MSOX
8
1
54
3,291
Russel 2000 and 3000 index inclusion Another incredible milestone after years of suffering on the OTC/pink sheets Congrats @rivers_kim $TRLV $MSOS $MSOX
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices $TRLV investors.trulieve.com/2026-…
2
1
28
1,098
$MSOS can’t catch a break
BREAKING: Prominent Democrats are now calling for Attorney General Todd Blanche to be impeached over his handling of the Epstein files.
5
5
1,262
$GTBIF is a $13-14 stock today (100%+ above current price) if rerated to the avg multiple of $TRLV and $CURLF Strong argument it should trade at a premium Zero meaningful liquidity without uplisting $MSOS $MSOX
2
2
1
38
2,040
Stay order on cannabis rescheduling lifts today. Solid earnings across the board. ALJ decision imminent $MSOS $TRLV $GTBIF $CURLF
3
2
45
1,846
Key takeaway from the top 3 cannabis earnings reports $CURLF $TRLV $GTBIF… $GTBIF is criminally undervalued $MSOS $MSOX
3
3
3
40
1,913
First full Qtr medical only, deconsolidation of Harvest assets was on June 3. Revenue up 3.6% QoQ on comparable medical only, large cash position, real earnings power. Georgia ramping. Well done $TRLV $MSOS
Trulieve Reports Third Quarter 2026 Results $TRLV investors.trulieve.com/2026-…
18
852
The fucked up punitive cannabis tax structure in one picture. $28M tax on $21M pre tax income $MSOS $GTBIF $MSOX
1
6
886
trading 4.8x CASH on balance sheet and 4.2x LQA EBITDA $GTBIF
2
1
8
618
trading 4.8x CASH on balance sheet and 4.2x LQA EBITDA $GTBIF
2
1
8
618
Our Q3 2026 results highlight growth across our retail and CPG businesses, including the addition of 6 RISE Dispensaries. Thank you to everyone across Green Thumb for making it possible! Read the full results and join today's earnings call at 4 p.m. CT. $GTBIF investors.gtigrows.com/news-…
12
677
$JUSH looks like the best valuation/catalyst mix among the Tier 2s. Roughly $100M equity value and $290M EV. Trading at 5.7x ’26E and 4.0x ’27E EBITDA. Cacioppo (CEO) bought ~$1M in the open market through One East in Aug/Sept around $0.50. Virginia: adult-use sales scheduled for July ’27, with six large stores already built. Assigned HSA II covers the densely populated Northern Virginia and Washington, D.C. metropolitan region (approximately 2.6 million residents) Capex now is on added flowering rooms, extraction and a greenhouse under construction targeting early ’27. Management expects those initial projects to lift 2027 harvests ~60%. A larger Manassas expansion would roughly double indoor canopy with first harvest targeted for ’28. Ohio and NJ are contributing growth. PA adult-use offers another potential step function opportunity. Wholesale just grew 40%. Debt is substantial but termed out and the larger expansion still needs financing. Attractive M&A target $MSOS $MSOX
1
4
347
Friendly reminder US Cannabis is trading at avg 1x sales 5x EBITDA into major catalysts. Tier 2 names trading even cheaper. Rerating will be violent $MSOS $TRLV $GTBIF $CURLF $VREOF $CRLBF $VRNO $GLAS $MSOX
2
18
1,319
Full legalization/deschedule probability now much > 50%. S3 adult use, banking and capital markets are locked and expedited. PA adult use incoming. $MSOS in single digits won’t last long. Perfect storm upon us $TRLV $CURLF $GTBIF $VREOF $VRNO $GLAS $CRLBF $TSND $JUSH
2
1
50
2,271